Medical device manufacturing company in the respiratory industry.
Fisher & Paykel Healthcare
ResMed
Intersurgical
Philips
Drager
Medtronic
Pulmodyne
Teleflex
O_Two
SunMed
Ambu
Vapotherm
Vygon
The industries are operating on a global market revenue basis.
The global therapeutic and diagnostic respiratory devices and equipment market was valued at around $12 billion in 2018 and is predicted to increase at a CAGR of 2.2 percent to $14 billion by 2022.
Sales of respiratory devices and equipment, as well as related services, constitute the therapeutic and diagnostic market for respiratory devices and equipment. Respiratory devices and equipment are used to provide medication or aid a patient who is having trouble breathing and is not getting enough oxygen to stay alive. Respiratory devices and equipment are required for patients with respiratory illnesses such as asthma, cystic fibrosis, chronic obstructive pulmonary disease, and acute respiratory distress syndrome.
The rise in disorders such as chronic obstructive pulmonary disease (COPD), asthma, and lung cancer will drive the global therapeutic respiratory devices and equipment market. The global therapeutic respiratory devices market is being driven by the rise in the elderly population, tobacco smoking, allergens, and air pollution, all of which are increasing the prevalence of respiratory disorders. According to the World Health Organization, tobacco use kills 4.9 million people each year, with 1 million deaths from chronic obstructive pulmonary disease, 1.6 million deaths from cardiovascular and respiratory disorders, and 0.9 million deaths from lung cancer.